<DOC>
	<DOCNO>NCT02935101</DOCNO>
	<brief_summary>The purpose study evaluate whether prednisolone lower intensity frequency crave heroin-addicted subject undertake detoxification cocaine and/or heroin .</brief_summary>
	<brief_title>Effects Glucocorticoids Craving During Detoxification Treatment Heroin and/or Cocaine</brief_title>
	<detailed_description>Participants study 120 heroin-addicted patient inward detoxification program either cocaine cocaine heroin . Depending detoxification substance ( ) two group participant : Detoxification cocaine ( A ; 60 participant ) detoxification heroin cocaine ( B ; 60 participant ) . The detoxification start mandatory admission ward last 1-2 week . The participation study last 4-5 week ( include follow-up visit ) . Intake study medication start two day admission one day inform consent . Each participant get either 30mg/d prednisolon placebo five day . Participants normal medical supervision treatment phase follow-up 2 ( final examination ) provide ward staff . Treatment day follow-up 1 2 consist : ( 1 ) vital sign ( BP , HR , temperature ) measure daily routine , ( 2 ) midday : visual analogue scale ask crave heroin cocaine moment , ( 3 ) afternoon : questionnaire survey mainly withdrawal symptom vegetative parameter .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Heroin</mesh_term>
	<criteria>Informed Consent document signature , age ≥18 , ICD10 diagnosis F11.2 ( opioid addiction syndrome ) ; subject may already get partial substitution treatment , ICD10 diagnosis : F14.2 ( cocaine addiction syndrome ) . admission detoxification ward U2 University Psychiatric Hospital Basel contraindication class drug study excipients , e.g . know hypersensitivity allergy class drug investigational product ; acute severe comorbid psychiatric disturbance ( heavy episode major depression suicidal ideation , acute exacerbation bipolar disorder , acute exacerbation schizophrenia , alcohol addiction acute relapse , psychosis , dementia ) ; current medical condition exclude participation ( acute infectious disease , monitor elevate CRP , diabetes mellitus , anticoagulation therapy ) ; recent history systemic topic glucocorticoid therapy ; alcohol intake &gt; 0.0 ‰ accord breathalyser test day 0 ( screen ) exclude severe alcohol abuse ; specific drug allow study specific period time prior administration test dose : Anticoagulant agent , antidiabetic agent , cyclosporine ; woman pregnant breast feeding ; intention become pregnant course study ; inability follow procedure study , e.g . due language problem , psychological disorder , dementia ; participation another study investigational drug within 30 day precede present study ; previous enrolment current study ; enrolment investigator , his/her family member , employee dependent person .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>glucocorticoid</keyword>
	<keyword>crave</keyword>
	<keyword>Heroin</keyword>
	<keyword>Cocaine</keyword>
	<keyword>dependency</keyword>
</DOC>